Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: An Australian and New Zealand Gynaecological Oncology Group study
P Harnett*, M Buck, P Beale, A Goldrick, S Allan, B Fitzharris, P De Souza, M Links, G Kalimi, T Davies, R. Stuart-Harris
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
Dive into the research topics of 'Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: An Australian and New Zealand Gynaecological Oncology Group study'. Together they form a unique fingerprint.